基本信息
浏览量:311
职业迁徙
个人简介
Sara Tolaney, MD, MPH is a breast medical oncologist at Dana-Farber Cancer Institute. Dr. Tolaney has earned both a strong national and international reputation as a talented clinical investigator and is key opinion leader in breast oncology. She has done extensive work on de-escalating therapy for patients with low-risk HER2-positive breast cancer, having developed a less toxic treatment regimen associated with a clinically low event rate. This regimen is incorporated into national and international treatment guidelines, and she has follow-up multi-institutional studies ongoing to evaluate if even less toxic therapies may have a role in these patients. She also been instrumental in the development of cdk 4/6 inhibitors in breast cancer, and served as the international co-PI for the first randomized study of cdk 4/6 inhibitors in HER2-positive breast cancer. Moreover, she has played a pivotal role in developing a series of investigator initiated clinical trials in immunotherapy, with strong translational endpoints, and serves as the Director for Breast Immunotherapy Clinical Research at DFCI. Dr. Tolaney has also been instrumental in overseeing the Breast Oncology Clinical Trials program, one of the largest clinical research programs at DFCI. Additionally, she serves as the Associate Director of the Susan F. Smith Center for Women’s Cancers, and chairs the Scientific Steering Committee for this group. Importantly, Dr. Tolaney is also an outstanding clinician, recognized by her peers for her excellent patient care with the “Lee Nadler Extra Mile Award” and is a Senior Physician at DFCI.
研究兴趣
论文共 634 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Laura M. Spring,Bogang Wu, Ting Liu, Jacob Geisberg,Simona Cristea,Veerle Bossuyt, Rachel Occhiogrosso Abelman, Nicole Peiris,James Coates,Siang-Boon Koh, Mengran Zhang,Lianne Ryan,
Clinical cancer research : an official journal of the American Association for Cancer Researchno. 1 (2024): 39-49
Current Oncology Reportsno. 1 (2024): 21-33
Cancer Researchno. 9_Supplement (2024): PS11-01
Annals of Surgical Oncologyno. 4 (2024): 2244-2252
npj Breast Cancerno. 1 (2023): 1-5
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
ONCOLOGY-NEW YORKno. 7 (2023): 274-275
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn